Dates: 26 October 2021 - 8 November 2021

Location:

Live Q&A webinar:
Wednesday 3 November 16:00 – 17:30

Pre-recorded lecture videos and slides available:
26 October to 8 November 2021

Organiser: BMS

Duration: n/a

CPD: 6

Overview:

We are delighted to offer our annual Women’s Health Meeting with Mr Haitham Hamoda as a virtual meeting. Following its great success in 2020, together with Mr Hamoda, we are developing a full programme of lectures to provide you with up-to-date, evidence-based menopause and post-reproductive health education.

You will have access to pre-recorded videos of all the lectures, with lecture slides, for a two week period from 26 October to 8 November 2021. A one and a half hour Zoom webinar will then be hosted by Mr Hamoda on Wednesday 3 November at 16:30, giving you an opportunity to ask questions and reinforce your learning. You will be able to pre-submit questions via the BMS website while you are viewing the lectures, for discussion during the Q&A webinar. The live Q&A webinar will be recorded and made available shortly after the event to watch at your convenience.

Delegates will also have access to a virtual exhibition. Participating healthcare and pharmaceutical companies will showcase their latest products with a range of literature and short videos.

The meeting carries 6 CPD credits and is open to all healthcare professionals – GPs, clinic doctors, gynaecologists, specialist and practice nurses, SRH specialists, O&G and GP trainees. We also welcome anyone allied to the healthcare profession with an interest in women’s health.

2020 saw the successful launch of the Virtual BMS Women’s Health Meetings allowing us to offer you all the benefits of high-quality BMS education whilst giving you the versatility to learn when and where is convenient for you.

Booking: The full meeting programme is being finalised. Please register your interest and we shall send you an email when registration opens.
Enquiries: Nadine Verstringhe: nadine.verstringhe@bms-whc.org.uk

This meeting is financially supported in part by the pharmaceutical industry through sponsorship but it has no influence over the meeting agenda. All lecturers are required to make a formal declaration of interests at the beginning of their presentation.